Inc. ("Somaxon" or the "Company") (Nasdaq- SOMX) relating to the proposed acquisition by Pernix Therapeutics Holdings, Inc. ("Pernix"). Under the terms of the transaction, Somaxon shareholders will receive only $25 million in Pernix …
Embattled Somaxon Pharmaceuticals (Nasdaq: SOMX), which ... to merge with Pernix Therapeutics Holdings (NYSE: PTX) in a deal valued at $25 million. Pernix, based in suburban Houston, agreed to issue $25 million in shares of its …
San Diego
The stock needs to break out above $2.07 to go higher. ( click to enlarge ) SOMX - As we can see on the daily chart, the stock has been on a short term downtrend since April. Stochastics are in oversold territory, and the stock is about to …
SOMX fell 0.6 percent to $3.29 yesterday and is down 26 percent in the last month. The stock attempted to rally in August after announcing a deal with Procter & Gamble to distribute its Silenor sleeping medicine, but it encountered a flood of …
Also, Buffett said he learned earlier this month that Sokol bought nearly 100,000 shares of Lubrizol stock before recommending that Berkshire buy the chemical ... (ACRX), (PCRX), (SOMX) Have Been Investment Banking Clients Of …
Somaxon Pharmaceuticals (SOMX) looks to have found a bottom and is trying to make ... Nevertheless, the medium-term trend is still weak as the stock has been trading below 50-dma and 200-dma with 50-day moving average going …
sales annualizing at $20 million based on most recently reported quarterly sales data * SOMX’s Silenor (doxepin); novel sleep aid; approved Mar 2010; sales annualizing at <$1 million based on most recently reported quarterly sales data …
f_ticker=somx]Read the full analyst report on SOMX[/url] These 7 were hand-picked from the list of 220 Zacks Rank #1 Strong Buys with earnings estimate revisions that are sweeping upward. Their stock prices are expected to rise sooner …
Awaiting
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
The Bedford Report releases stock research on the Biotechnology Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at …